Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1613 1615 1722 1795 3785
This examiner grants 69% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18649602 | SUSPENSIONS OF RADIOPAQUE CROSSLINKED HYDROGEL PARTICLES IN CARRIER FLUIDS CONTAINING BIOCOMPATIBLE HYDROPHILIC POLYMERS | Final Rejection | Boston Scientific Scimed, Inc. |
| 18827625 | STORAGE STABLE MIXTURES | Non-Final OA | DSM IP Assets B.V. |
| 18488521 | Aerosol Personal Care Products | Final Rejection | The Procter & Gamble Company |
| 17082929 | 5HT AGONISTS FOR TREATING DISORDERS | Final Rejection | The Regents of the University of California |
| 17798336 | COSMETIC | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 17762448 | HYPOCHLORITE COMPOSITION AND SYSTEM AND METHOD FOR PREPARING A HYPOCHLORITE COMPOSITION AND USE OF THE SAME | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18870008 | COSMETIC HAIR TREATMENT PROCESS, COMPRISING A WASHING STEP, A STEP OF APPLYING A COSMETIC COMPOSITION COMPRISING AMINO ACIDS AND HYDROXYLATED (POLY)CARBOXYLIC ACIDS, AND THEN A CONDITIONING STEP | Non-Final OA | L'OREAL |
| 18906267 | Compositions Containing Trihydroxystearin and Oil For Inhibiting Trihydroxystearin Crystallization | Non-Final OA | L'OREAL |
| 17162392 | CLEANSING COMPOSITION PROVIDING ENHANCED DEPOSITION OF SALICYLIC ACID FOR ACNE TREATMENT | Non-Final OA | L'OREAL |
| 18042092 | TARGETING CARTILAGE EGFR PATHWAY FOR OSTEOARTHRITIS TREATMENT | Final Rejection | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 18717936 | Oral Care Compositions with Hyaluronic Acid | Non-Final OA | Colgate-Palmolive Company |
| 18559736 | SQUEEZE FOAMER AND CONCENTRATES | Non-Final OA | BEIERSDORF AG |
| 18313754 | BIODEGRADABLE POLYCAPROLACTONE CAPSULE FOR ANTIBODY RELEASE AND DEGRADATION | Non-Final OA | University Of Cincinnati |
| 17908035 | COATED SPONGES | Non-Final OA | Dow Silicones Corporation |
| 18247508 | CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN | Non-Final OA | KAO CORPORATION |
| 18572983 | Method to Control Administration of Active Substance to the Digestive Tract | Final Rejection | Lonza Greenwood LLC |
| 18410324 | TWO-COMPONENT COMPOSITION | Final Rejection | ASAMEDIC AS |
| 18038392 | LONG-ACTING AND LONG-CIRCULATING DELIVERY VEHICLES | Non-Final OA | The Brigham and Women`s Hospital, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy